[Genome-wide association studies]

Dtsch Med Wochenschr. 2011 Jan;136(3):95-8. doi: 10.1055/s-0030-1269446. Epub 2011 Jan 11.
[Article in German]

Abstract

Genome-wide association studies (GWAS) are aimed to identify genetic markers of complex human diseases and individual traits. In this context more than 150 gene loci have been found to be associated with about 60 different diseases and personal characteristics. A recent example is the relevance of a polymorphism in the interleukin 28B gene for the natural course of hepatitis C virus infection and the efficacy of antiviral therapy. It is to be expected that GWAS will increasingly contribute to the understanding of the pathogenesis and consquently improve prediction, prevention, diagnosis and therapy of human diseases and eventually will become part of clinical practice.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Chromosomes, Human, Pair 19 / genetics
  • Genetic Markers / genetics*
  • Genetic Predisposition to Disease / genetics*
  • Genome-Wide Association Study / methods*
  • Genotype
  • Haplotypes / genetics
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / genetics
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Interferons
  • Interleukins / genetics
  • Phenotype
  • Polyethylene Glycols / therapeutic use
  • Polymorphism, Single Nucleotide / genetics
  • Quantitative Trait Loci / genetics
  • Recombinant Proteins
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Genetic Markers
  • interferon-lambda, human
  • Interferon alpha-2
  • Interferon-alpha
  • Interleukins
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Interferons
  • peginterferon alfa-2b
  • peginterferon alfa-2a